Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The administration of ascorbic acid seemed to increase the iron available for erythropoiesis,
thus improving the anemia response to the treatment.
The investigators therefore aimed to evaluate the effects of intravenous ascorbic acid
administration in hemodialysed patients with iron overload.